A new document titled "Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade" highlights the key questions that need to be answered in order to develop new TB vaccines and quickly and efficiently as possible.
Earlier this week, 12 cases of virtually incurable tuberculosis strains were reported at a hospital in India. The emergence of what many people are calling "totally drug-resistant tuberculosis (TDR TB)" is a frightening global health threat since these strains could spread.
Kaitlin Christenson of the Global Health Technologies Coalition (GHTC), Jim Connolly of Aeras and Mel Spigelman of the TB Alliance write about the need for high-income countries to fund the development of new tuberculosis technologies for The Hill's Congress Blog.
The need for a global immunization program designed for the mass immunization of non-infant age groups with TB vaccines and formation of a new expert advisory committee on TB vaccines are two of the major recommendations by a panel of experts, announced January 6th by the World Health Organization in its Weekly Epidemiological Record.
The positive news on malaria vaccine development announced this week has provided a boost to all of us who are working to develop new vaccines to fight infectious diseases that impact the poorest and most vulnerable communities.